CP Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band 122.2 kDa observed
Observed band 122.2 kDa observed
Gel 8-10%
Positive control Adipose tissue
Negative control Adipose tissue
Important caveats
Reasons your observed band may differ from the expected size.
Calculated mass122.2 kDa
LocalizationSecreted
Processing / PTMRecord-dependent
ReactivityHuman
Section 1

Real Curated CP Western Blot Protocols

Start with the molecular-weight rule, then compare verified publication-derived conditions.

Recommended Western blot protocol parameters
Sample / lysateAdipose tissue
Gel %8-10%
Load20-30 µg total protein per lane
TransferWet/tank, extended transfer
Membrane0.45 µm PVDF
Blocking5% non-fat milk or 5% BSA in TBST
PrimaryPB9852 at datasheet starting dilution
Primary incubationOvernight at 4 °C with gentle agitation
SecondarySpecies-matched HRP conjugate at validated dilution
Wash3 × 5 min in TBST
DetectionChemiluminescent substrate
ExposureBracket exposures to avoid saturation
Section 2

What Is the Expected CP Western Blot Band Size?

Use the product-observed 122.2 kDa band as the primary planning value and retain the UniProt calculated mass as context.

What am I looking at on my blot?
122.2 kDaMatches the authoritative product WB observation.
122.2 kDa calculatedUse as UniProt context, not as a replacement observed band.
Unexpected additional signalDo not assign identity without orthogonal positive/negative controls.
💡Expected CP appearancePlan around 122.2 kDa and keep the calculated mass as supporting context.
How each factor affects band size
Catalog-observed band122.2 kDa; use this as the primary experimental expectation.
Calculated mass122.2 kDa from UniProt P00450; retain as context.
Gel selection8-10%; shared with the recommended protocol and poster.
Specificity checkCompare the lead HPA positive and negative controls with PB9852.
Why is my band missing or off?
SituationLikely causeNext action
122.2 kDaMatches the authoritative product WB observation.Confirm with orthogonal controls and the linked product record.
Additional bandMay reflect processing, modification, or non-specific signal.Run a dilution series and compare positive/negative controls.
Weak signalTarget abundance or transfer may be limiting.Verify transfer, increase positive-control abundance, and bracket exposure.

Sample controls for CP Western blot

🧪Use Adipose tissue as the first positive-control candidate and retain an orthogonal negative control.
Positive control: Adipose tissue (Not detected)
Negative control: Adipose tissue (Not detected)
HPA protein score determines control status; other expression data is supporting context only.

HPA tissue expression evidence for CP

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart on each tissue page — click any row's HPA link to view the source.

Positive expression · recommended positive controls

Tissue Cell type Level Evidence Source

Undetected expression · recommended negative controls

The Human Protein Atlas exposes no structured IHC tissue profile for CP, so tissue-level positive/negative controls cannot be listed here. Use a documented CP-positive lysate (recombinant CP or a known-expressing line) as the positive control and a CP knockdown/knockout lysate as the negative control; confirm against the antibody datasheet.
Tissue Cell type Level Evidence Source
Adipose tissue Reported tissue cells Not detected Protein (HPA) HPA →
Breast Reported tissue cells Not detected Protein (HPA) HPA →
Adrenal gland Reported tissue cells Not detected Protein (HPA) HPA →
Appendix Reported tissue cells Not detected Protein (HPA) HPA →
Appendix Reported tissue cells Not detected Protein (HPA) HPA →
Bone marrow Reported tissue cells Not detected Protein (HPA) HPA →
Section 3

Advanced CP Western Blot Tips

Deeper troubleshooting and optimisation questions for CP, answered from its protein features.

Which band should guide the blot?
Use 122.2 kDa, the observation attached to the authoritative PB9852 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 122.2 kDa expectation.
Which positive control should I start with?
Start with Adipose tissue, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Adipose tissue as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 8-10% consistently across the quick facts, protocol table, and poster.
What transfer method to use for CP Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should PB9852 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents

CP Western Blot Reagents

Human-reactive CP Western blot reagents with authoritative product imagery.

Real WB dataWestern blot validation image for CP using PB9852; observed band 122.2 kDa
Anti-Ceruloplasmin/CP Antibody Picoband®
Cat # PB9852

Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.

Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.